Latest news from SEQENS Group

All news

Events General General PERSONAL CARE Press release Products & Technologies Protéus SD-CSR

SEQENS announces the appointement of a new CEO

France-based SEQENS, a leader in the development and production of active pharmaceutical ingredients, pharmaceutical intermediates, and specialty ingredients, announces that Pascal Villemagne has been named Chief Executive Officer, effective 1st April 2025. Pascal brings a wealth of experience to the role, having previously served as CEO of CARBOGEN AMCIS, a company specializing in the manufacture … Continued

Read more

A new article published by Proteus in the special issue of OPRD journal

The Seqens CDMO site from Lahr reaches the Gold – EcoVadis level.

Covid-19: the benefits of flow chemistry & biocatalysis

COVID-19: SEQENS mobilizes its innovation department

A biocatalytic approach to improve the synthesis of Danoprevir

Isopropanol: Seqens plans to invest in a new production plant

Futurol’s first contract for a second-generation ethanol plant in Croatia

Covid-19: Seqens Group remains fully mobilized

Information on Seqens crisis management related to Covid-19

Seqens is certified EcoVadis

Products & Technologies

Seqens and Bordeaux INP launch a new Labcom : SPRINT

Seqens group, member of the Global Compact

Contact